Bristol Myers Squibb (BMS) announced the establishment of a new facility in Hyderabad with the potential to employ approximately 1,500 people over the next few years in order to expand their global drug development.
Their new city location will help them pursue therapies at the cutting edge of scientific discovery, with the goal of bringing an exciting new generation of life-changing treatments to patients.
“The new site will specifically expand its global footprint and draw on the dynamic science and technology talent in the region,” according to a press release.
Telangana IT minister KT Rama Rao held a meeting with the managing director of BMS, Dr Samit Hirawat, executive vice president, chief medical officer, global drug development at BMS, who is in Hyderabad to participate in the 20th edition of the annual international convention BioAsia 2023.
Principal secretary Jayesh Ranjan and CEO, of Telangana life sciences, Shakthi M. Nagappan, were also present at the meeting.
ALSO READ: Dispute redressal should be in a time-bound manner, says KTR
Speaking after the announcement was made, KTR said, “I am delighted to welcome BMS to the vibrant ecosystem of Hyderabad. I strongly believe this partnership with BMS is a strategic one.”
“I am confident that the center will engage in cutting-edge R&D and digital work and will provide a great opportunity for our extraordinary talent pool to engage in some highly impactful work,” KTR added.
BMS MD, Hirawat said, “Our new BMS site in Hyderabad will also create significant employment and economic opportunities locally as we continue to grow our presence in the years ahead.”
(This story has been sourced from a third-party syndicated feed, agencies. Raavi Media accepts no responsibility or liability for the text’s dependability, trustworthiness, reliability, and data. Raavi Media management/ythisnews.com reserves the sole right to alter, delete or remove (without notice) the content at its absolute discretion for any reason whatsoever.)